Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

Appetite drug shows promise in treating obesity

By John Blundell, Professor of Psychobiology, University of Leeds
A recently published clinical trial of the anti-obesity drug, semaglutide, has produced a degree of weight loss which has led some to dub the medication a “game changer” in the treatment of obesity.

The trial looked at 1,961 adults who were overweight or obese. Approximately 75% of participants were female. Participants were given a weekly injection of semaglutide, a drug normally used to control blood…The Conversation


Read complete article

© The Conversation -
Subscribe to Tolerance.ca


Follow us on ...
Facebook Twitter